Lv21
140 积分 2025-10-28 加入
Safety and efficacy of factor XIa inhibition with milvexian for secondary stroke prevention (AXIOMATIC-SSP): a phase 2, international, randomised, double-blind, placebo-controlled, dose-finding trial
4小时前
待确认
[Guidelines for the diagnosis and treatment of acute pulmonary embolism 2025]
1天前
已完结
Asundexian for Secondary Stroke Prevention
11天前
已完结
A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction
11天前
已完结
Factor XIa inhibition with asundexian after acute non-cardioembolic ischaemic stroke (PACIFIC-Stroke): an international, randomised, double-blind, placebo-controlled, phase 2b trial
11天前
已完结
Development and in vitro-in vivo evaluation of a novel sustained-release tablet based on constant-release surface
1个月前
已完结
A Novel Imaging Technique to Investigate the Influence of Atomization Air Pressure on Film–Tablet Interfacial Thickness
1个月前
已完结
Association of Lipoprotein(a) With Severe Degenerative Aortic Valve Stenosis
1个月前
已完结
Multiomics Analysis Reveals Stromal Cell State Changes and INHBA-Associated Remodeling in Calcific Aortic Valve Disease
1个月前
已完结
Application of problem based learning (PBL) and casebased learning (CBL) in the teaching of internationalclassification of diseases encoding
3个月前
已完结
皖公网安备34019202002308
